Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
An interdisciplinary team with extensive garden study experience conducted a pilot randomized controlled clinical trial to see whether gardening reduced risk factors for diseases like cancer and heart disease. The pilot trial will provide preliminary data on associations between human microbiome, diet, physical activity, and social interactions and the outcomes of weight status and key inflammatory biomarkers.
The pilot study will lead to development of a future, large randomized controlled clinical trial, by fulfilling the following aims:
Pilot Aim 1: Demonstrate feasibility of recruitment and ability to perform study procedures.
Pilot Aim 2: Demonstrate the ability to measure accurately chronic disease risk factors such as diet, physical activity, weight gain, microbiome characteristics and inflammatory biomarkers.
Pilot Aim 3: Provide preliminary results on the efficacy of gardens as a preventive intervention, and estimates for a detailed power analysis for the proposed subsequent larger trial.
Aim 3a: Demonstrate that compared to non-gardeners, gardeners have 1) greater intake of fruits and vegetables; 2) better Healthy Eating Index (HEI); 3) lower Diet Inflammatory Index (DII); 4) reduced sedentary time and increased moderate-to-vigorous physical activity (MVPA); and reduced age-associated weight gain.
Aim 3b: For gardeners and non-gardeners, sample garden soil, gut, skin, and oral microbiome at six time points from April through September to characterize and compare bacterial load, pathogenic taxa, taxonomic diversity, relative dominance, indicator taxa, and metabolomic results.
Aim 3c: Demonstrate that gardening reduces inflammatory biomarkers linked to heart disease and cancer, including CRP, IL1b, IL4, IL6, IL10, and TNFa, and that the effect of gardening is mediated by diet, weight gain, physical activity and characteristics of the microbiome.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Community Garden Intervention Group | Experimental | Participants randomized to the Community Garden Intervention Group will receive the garden intervention. Participants will be assigned a plot for one season and will receive a standard package of services and amenities to support participation in the community garden, including seeds and transplants, tools, new garden classes and access to master community gardeners in Denver. |
|
| Wait List Control Group | No Intervention | The non-gardening group will remain on the DUG wait lists and will not receive the garden intervention. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Community Garden Intervention | Behavioral | The investigators will recruit 30 prospective gardeners who have not been gardening for the past two years and who are listed on Denver Urban Gardens (DUG) wait lists. DUG randomly assigns people on each garden wait list to available plots, using a lottery. This creates a natural randomized experiment. Participants randomized to the garden intervention will receive a standardized garden resource package, which includes the following:
The non-gardening group will remain on the DUG wait lists and will not receive these resources. Duration of the intervention is 1 year. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in fruit and vegetable intake from baseline at 20 weeks | 6 24-hour diet recalls will be collected at random | Measurements will occur during weeks 1-2 (3 random recalls) and weeks 18-20 (3 random recalls) |
| Change in sedentary time behavior from baseline at 20 weeks | Accelerometers will be adhered to thigh and collect data for 7 days | 2 measurements over 6 months, T1 (Week 1) and T6 (Week 20) |
| Change in bacterial load from baseline at 20 weeks | Microbiome data will be collected six time points using 1 gut, 2 skin, and 1 oral samples | Every 3-4 weeks up to 20 weeks (Week 1, Week 4, Week 7, Week 10, Week 14, Week 18) |
| Change in moderate-to-vigorous physical activity (MVPA) from baseline at 20 weeks | Accelerometers will be adhered to thigh and collect data for 7 days | 2 measurements over 6 months, T1 (Week 1) and T6 (Week 20) |
| Change in weight (kg) from baseline at 20 weeks | Objective measurements of weight will be collected | 2 measurements over 6 months, T1 (Week 1) and T6 (Week 20) |
| Change in waist circumference from baseline at 20 weeks | Objective measurement of waist circumference | 2 measurements over 6 months, T1 (Week 1) and T6 (Week 20) |
| Change in pathogenic taxa from baseline at 20 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in HbA1C from baseline at 20 weeks | 20 weeks | |
| Change in blood pressure from baseline at 20 weeks | 20 weeks | |
| Change in lipid profile from baseline at 20 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jill S Litt, PhD | University of Colorado, Boulder | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Colorado Boulder | Boulder | Colorado | 80303 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D015430 | Weight Gain |
| D002908 | Chronic Disease |
| D057185 | Sedentary Behavior |
| D015438 | Health Behavior |
| D009765 | Obesity |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D001836 | Body Weight Changes |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Microbiome data will be derived from 1 gut, 2 skin, and 1 oral samples
| Every 3-4 weeks up to 20 weeks (Week 1, Week 4, Week 7, Week 10, Week 14, Week 18) |
| Change in taxonomic diversity from baseline at 20 weeks | Microbiome data will be derived from 1 gut, 2 skin, and 1 oral samples | Every 3-4 weeks up to 20 weeks (Week 1, Week 4, Week 7, Week 10, Week 14, Week 18) |
| Change in relative dominance from baseline at 20 weeks | Microbiome data will be derived from 1 gut, 2 skin, and 1 oral samples | Every 3-4 weeks up to 20 weeks (Week 1, Week 4, Week 7, Week 10, Week 14, Week 18) |
| Change in indicator taxa from baseline at 20 weeks | Microbiome data will be derived from 1 gut, 2 skin, and 1 oral samples | Every 3-4 weeks up to 20 weeks (Week 1, Week 4, Week 7, Week 10, Week 14, Week 18) |
| Change in Inflammatory biomarkers from baseline at 20 weeks | Samples include hs-CRP, TNF-alpha, IL1b, IL4, IL6, IL10 | 20 weeks |
Including LDL, HDL, total cholesterol, triglycerides |
| 20 weeks |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |